395
Views
2
CrossRef citations to date
0
Altmetric
Case Reports

Preserved Residual Kidney Function after Twelve Years' Hemodialysis

, , , , , , & show all
Pages 740-742 | Received 08 Apr 2009, Accepted 31 May 2009, Published online: 09 Oct 2009

REFERENCES

  • Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12:2158–2162.
  • Termorshuizen F, Dekker FW, van Manen JG, Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: An analysis of the Netherlands Cooperative Study on the adequacy of Dialysis (NECOSAD)–2. J Am Soc Nephrol. 2004;15:1061–1070.
  • Misra M, Vonesh E, Van Stone JC, Effect of cause and time of dropout on the residual GFR: A comparative analysis of the decline of GFR on dialysis. Kidney Int. 2001;59:754–763.
  • Jansen MA, Hart AA, Korevaar JC, Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62:1046–1053.
  • Suda T, Hiroshing K, Ohta T, The contribution of residual renal function to overall nutritional status in chronic haemodialysis patients. Nephrol Dial Transplant. 2000;15:396–401.
  • Wang AY, Lai KN. The importance of residual renal function in dialysis patients. Kidney Int. 2006;69:1726–1732.
  • Moist LM, Port FK, Orzol SM, Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11:556–564.
  • Canaud B, Chenine L, Leray-Moragues H, Wiesen H, Tetta C. Residual renal function and dialysis modality: Is it really beneficial to preserve residual renal function in dialysis patients? Nephrology. 2006;11:292–296.
  • McKane W, Chandna SM, Tattersall JE, Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int. 2002;61:256–265.
  • Schiffl H, Lang SM, Fischer R. Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients. Nephrol Dial Transplant. 2002;17:1814–1818.
  • Brewster UC, Perazella MA. The renin-angiotensin-aldosterone system and the kidney: Effects on kidney disease. Am J Med. 2004;116:263–272.
  • Suzuki H, Kanno Y, Sugahara S, Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis. 2004;43:1056–1064.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.